What is NDC 50090-0896?

50090-0896 is the product NDC for Gabapentin, Gabapentin 300 mg/1 capsule, listed with the FDA by A-S Medication Solutions. It has 10 package NDCs, shown above in 10- and 11-digit form.

A-S Medication Solutions, NDC labeler code 50090. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Gabapentin?

561 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Gabapentin NDC 50090-0896 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)50090-0896Labeler and product segments. Claims need a package NDC.

Product NDC at billing width50090-0896Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
50090-0896-0	5009008960050090089600	100 CAPSULE in 1 BOTTLE (50090-0896-0)Marketed from Nov 28, 2014
50090-0896-1	5009008960150090089601	30 CAPSULE in 1 BOTTLE (50090-0896-1)Marketed from Nov 28, 2014
50090-0896-2	5009008960250090089602	60 CAPSULE in 1 BOTTLE (50090-0896-2)Marketed from Nov 28, 2014
50090-0896-3	5009008960350090089603	120 CAPSULE in 1 BOTTLE (50090-0896-3)Marketed from Nov 28, 2014
50090-0896-4	5009008960450090089604	90 CAPSULE in 1 BOTTLE (50090-0896-4)Marketed from Nov 28, 2014
50090-0896-5	5009008960550090089605	240 CAPSULE in 1 BOTTLE (50090-0896-5)Marketed from Nov 28, 2014
50090-0896-6	5009008960650090089606	270 CAPSULE in 1 BOTTLE (50090-0896-6)Marketed from Oct 24, 2017
50090-0896-7	5009008960750090089607	15 CAPSULE in 1 BOTTLE (50090-0896-7)Marketed from Aug 7, 2018
50090-0896-8	5009008960850090089608	42 CAPSULE in 1 BOTTLE (50090-0896-8)Marketed from May 15, 2024
50090-0896-9	5009008960950090089609	14 CAPSULE in 1 BOTTLE (50090-0896-9)Marketed from Jun 18, 2024

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Gabapentin
Generic name (nonproprietary): gabapentin
Active ingredients: Gabapentin — 300 mg/1
Dosage form: Capsule
Route: Oral
Labeler: A-S Medication SolutionsNDC labeler code 50090
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 090858
Marketing start: Jan 29, 2011
Listing expires: Dec 31, 2027
Other FDA classes: Decreased Central Nervous System Disorganized Electrical Activity (Physiologic effect)
Identifiers: Product ID 50090-0896_994b09e4-1dac-4fb6-a9c7-b361a2e11c6bSPL ID 994b09e4-1dac-4fb6-a9c7-b361a2e11c6bSPL set ID 03031adf-d36b-45ec-944e-dfce5a5de91aRxCUI 310430, 310431, 310432UNII 6CW7F3G59X

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N450090089600 followed by a unit qualifier and the quantity

Package 50090-0896-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 28, 2026.

Indications (excerpt from the label)

Gabapentin is indicated for: • Management of postherpetic neuralgia in adults • Adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy Gabapentin is indicated for: • Postherpetic neuralgia in adults ( 1 ) • Adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 50090-0896

What is NDC 50090-0896?: 50090-0896 is the product NDC for Gabapentin, Gabapentin 300 mg/1 capsule, listed with the FDA by A-S Medication Solutions. It has 10 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Gabapentin.
What is the active ingredient?: Gabapentin.
Who is the labeler?: A-S Medication Solutions, NDC labeler code 50090. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Gabapentin?: 561 other product NDCs are listed under this name. See all Gabapentin NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Gabapentin NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Gabapentin	Gabapentin 800 mg/1	TabletOral	St. Mary's Medical Park Pharmacy	60760-943	60760-0943-3060760-0943-90
gabapentin	Gabapentin 300 mg/1	CapsuleOral	REMEDYREPACK INC.	70518-4763	70518-4763-00
Gabapentin	Gabapentin 100 mg/1	CapsuleOral	Cardinal Health 107, LLC	55154-0581	55154-0581-00
Gabapentin	Gabapentin 100 mg/1	CapsuleOral	Advanced Rx of Tennessee, LLC	80425-0595	80425-0595-0180425-0595-0280425-0595-03+1 more
Gabapentin	Gabapentin 300 mg/1	CapsuleOral	REMEDYREPACK INC.	70518-4746	70518-4746-0070518-4746-0170518-4746-02+1 more
Gabapentin	Gabapentin 100 mg/1	CapsuleOral	REMEDYREPACK INC.	70518-4742	70518-4742-0070518-4742-02
Gabapentin	Gabapentin 400 mg/1	CapsuleOral	REMEDYREPACK INC.	70518-4740	70518-4740-0070518-4740-01
Gabapentin	Gabapentin 300 mg/1	CapsuleOral	Cardinal Health 107, LLC	55154-0580	55154-0580-00
Gabapentin	Gabapentin 600 mg/1	Tablet, CoatedOral	Coupler LLC	67046-1233	67046-1233-03
Gabapentin	Gabapentin 200 mg/1	CapsuleOral	Trifluent Pharma, LLC	73352-231	73352-0231-01

All 562 Gabapentin NDCs

Other NDCs under ANDA 090858

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 090858
Product	Strength	Form · route	Labeler	Product NDC
Gabapentin	Gabapentin 100 mg/1	CapsuleOral	Major Pharmaceuticals	0904-6665
Gabapentin	Gabapentin 300 mg/1	CapsuleOral	Major Pharmaceuticals	0904-6666
Gabapentin	Gabapentin 400 mg/1	CapsuleOral	Major Pharmaceuticals	0904-6667
Gabapentin	Gabapentin 100 mg/1	CapsuleOral	Major Pharmaceuticals	0904-7613
Gabapentin	Gabapentin 300 mg/1	CapsuleOral	Major Pharmaceuticals	0904-7614
Gabapentin	Gabapentin 400 mg/1	CapsuleOral	Major Pharmaceuticals	0904-7615
Gabapentin	Gabapentin 300 mg/1	CapsuleOral	PD-Rx Pharmaceuticals, Inc.	43063-673
Gabapentin	Gabapentin 100 mg/1	CapsuleOral	A-S Medication Solutions	50090-3200
Gabapentin	Gabapentin 300 mg/1	CapsuleOral	A-S Medication Solutions	50090-4893
Gabapentin	Gabapentin 100 mg/1	CapsuleOral	A-S Medication Solutions	50090-7169
Gabapentin	Gabapentin 400 mg/1	CapsuleOral	Cardinal Health 107, LLC	55154-0579
Gabapentin	Gabapentin 300 mg/1	CapsuleOral	Cardinal Health 107, LLC	55154-0580
Gabapentin	Gabapentin 100 mg/1	CapsuleOral	Cardinal Health 107, LLC	55154-0581
Gabapentin	Gabapentin 100 mg/1	CapsuleOral	Cardinal Health 107, LLC	55154-3363
Gabapentin	Gabapentin 300 mg/1	CapsuleOral	Cardinal Health 107, LLC	55154-7992
Gabapentin	Gabapentin 400 mg/1	CapsuleOral	Cardinal Health 107, LLC	55154-7993
Gabapentin	Gabapentin 100 mg/1	CapsuleOral	Cardinal Health 107, LLC	55154-8194
Gabapentin	Gabapentin 300 mg/1	CapsuleOral	Cardinal Health 107, LLC	55154-8195
Gabapentin	Gabapentin 400 mg/1	CapsuleOral	Clinical Solutions Wholesale, LLC	58118-3224
Gabapentin	Gabapentin 100 mg/1	CapsuleOral	American Health Packaging	60687-580

Showing 20 of 39.